Literature DB >> 25534888

Hypophysitis: a single-center case series.

Brandon S Imber1, Han S Lee, Sandeep Kunwar, Lewis S Blevins, Manish K Aghi.   

Abstract

PURPOSE: The authors review their treatment experience and summarize clinical outcomes for patients with hypophysitis over the past 15 years.
METHODS: A retrospective analysis was conducted on patients with lymphocytic, granulomatous or IgG4-related hypophysitis treated from 1997 to 2014 at a single academic center. Patients' medical records were reviewed and binary logistic regression analysis was used to assess whether various clinical parameters were associated with improved outcomes including endocrine function, radiographic appearance and disease recurrence.
RESULTS: Twenty-one patients (13 women and 8 men) were identified with a median diagnosis age of 37.4 years. All but two patients (90%) were diagnosed histopathologically and the remaining two were diagnosed clinically with lymphocytic hypophysitis. 16 patients (76%) had lymphocytic hypophysitis, 3 (14%) had granulomatous hypophysitis, 1 (5%) had IgG4-related hypophysitis and 1 (5%) had mixed lymphocytic-granulomatous. Patients presented with various symptoms of expanding sellar mass with most common signs including headache (57%), polyuria/polydipsia (52%), vision changes (52%) and amenorrhea or decreased libido (48%). Pre-treatment endocrine evaluation revealed that 12 (57%) patients had complete anterior hypopituitarism, 11 patients (52%) had diabetes insipidus, ten patients (48%) had mild hyperprolactinemia and three patients (14%) had isolated endocrine axis deficiencies with partial gland function. We observed a broad diversity in pre-treatment imaging with common findings including uniform contrast enhancement (62%), thickened infundibulum (57%) and loss of hypophysis bright spot on T1 imaging (43%). Patients were treated with steroids and hormone supplementation as needed. 16 patients (76%) had recorded post-treatment MRI scans which revealed that half had radiographic improvement and half had stable or worsened post-treatment imaging. Only female gender was found to significantly predict improved odds of post-steroid radiographic improvement. For post-treatment endocrine evaluation, six patients (29%) did not have an evaluation on record, four patients (19%) had some improvement in at least one axis, seven patients (33%) had stable but non-worsened endocrine function and four patients (19%) had worsened endocrine function post-steroids.
CONCLUSIONS: Hypophysitis is an increasingly recognized diagnosis that can present with a broad array of radiographic and clinical features. Surgical biopsy can be helpful to make definitive diagnosis and may guide treatment decision-making.

Entities:  

Mesh:

Year:  2015        PMID: 25534888     DOI: 10.1007/s11102-014-0622-5

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  60 in total

1.  Rathke's cleft cyst associated with hypophysitis: MRI.

Authors:  H Daikokuya; Y Inoue; Y Nemoto; T Tashiro; M Shakudo; K Ohata
Journal:  Neuroradiology       Date:  2000-07       Impact factor: 2.804

2.  Anterior hypophysitis and Hashimoto's disease in a young woman.

Authors:  R B GOUDIE; P H PINKERTON
Journal:  J Pathol Bacteriol       Date:  1962-04

3.  A case of Mikulicz's disease (IgG4-related plasmacytic disease) complicated by autoimmune hypophysitis.

Authors:  M Yamamoto; H Takahashi; M Ohara; C Suzuki; Y Naishiro; H Yamamoto; Y Shinomura; K Imai
Journal:  Scand J Rheumatol       Date:  2006 Sep-Oct       Impact factor: 3.641

4.  Symptomatic Rathke's cleft cyst with hypophysitis.

Authors:  M J Wearne; P C Barber; A P Johnson
Journal:  Br J Neurosurg       Date:  1995       Impact factor: 1.596

5.  A radiologic score to distinguish autoimmune hypophysitis from nonsecreting pituitary adenoma preoperatively.

Authors:  A Gutenberg; J Larsen; I Lupi; V Rohde; P Caturegli
Journal:  AJNR Am J Neuroradiol       Date:  2009-07-23       Impact factor: 3.825

6.  Lymphomatoid granulomatosis. Evidence of immunophenotypic diversity and relationship to Epstein-Barr virus infection.

Authors:  J L Myers; P J Kurtin; A L Katzenstein; H D Tazelaar; T V Colby; J G Strickler; R V Lloyd; P G Isaacson
Journal:  Am J Surg Pathol       Date:  1995-11       Impact factor: 6.394

Review 7.  Lyphomatoid granulomatosis causing central diabetes insipidus: case report and review of the literature.

Authors:  P W Bushunow; V Casas; D B Duggan
Journal:  Cancer Invest       Date:  1996       Impact factor: 2.176

8.  Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly.

Authors:  B Swearingen; F G Barker; L Katznelson; B M Biller; S Grinspoon; A Klibanski; N Moayeri; P M Black; N T Zervas
Journal:  J Clin Endocrinol Metab       Date:  1998-10       Impact factor: 5.958

9.  Lymphocytic hypophysitis successfully treated with azathioprine: first case report.

Authors:  A Lecube; G Francisco; D Rodríguez; A Ortega; A Codina; C Hernández; R Simó
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-11       Impact factor: 10.154

Review 10.  Lymphocytic hypophysitis: disease spectrum and approach to diagnosis and therapy.

Authors:  Juan-Andres Rivera
Journal:  Pituitary       Date:  2006       Impact factor: 3.599

View more
  18 in total

Review 1.  Adrenal insufficiency.

Authors:  Stefanie Hahner; Richard J Ross; Wiebke Arlt; Irina Bancos; Stephanie Burger-Stritt; David J Torpy; Eystein S Husebye; Marcus Quinkler
Journal:  Nat Rev Dis Primers       Date:  2021-03-11       Impact factor: 52.329

Review 2.  Critical review of IgG4-related hypophysitis.

Authors:  Junpei Shikuma; Kenshi Kan; Rokuro Ito; Kazuo Hara; Hiroyuki Sakai; Takashi Miwa; Akira Kanazawa; Masato Odawara
Journal:  Pituitary       Date:  2017-04       Impact factor: 4.107

Review 3.  Primary hypophysitis and other autoimmune disorders of the sellar and suprasellar regions.

Authors:  Sriram Gubbi; Fady Hannah-Shmouni; Constantine A Stratakis; Christian A Koch
Journal:  Rev Endocr Metab Disord       Date:  2018-12       Impact factor: 6.514

Review 4.  IgG4-related hypophysitis.

Authors:  Alireza Amirbaigloo; Fatemeh Esfahanian; Marjan Mouodi; Nasser Rakhshani; Mehdi Zeinalizadeh
Journal:  Endocrine       Date:  2021-04-10       Impact factor: 3.633

5.  Outcomes of Initial Management Strategies in Patients With Autoimmune Lymphocytic Hypophysitis: A Systematic Review and Meta-analysis.

Authors:  Diane Donegan; Zeb Saeed; Danae A Delivanis; Mohammad Hassan Murad; Juergen Honegger; Felix Amereller; Seda Hanife Oguz; Dana Erickson; Irina Bancos
Journal:  J Clin Endocrinol Metab       Date:  2022-03-24       Impact factor: 5.958

6.  Preoperative differentiation of hypophysitis and pituitary adenomas using a novel clinicoradiologic scoring system.

Authors:  Kyla Wright; Hyon Kim; Travis Hill; Matthew Lee; Cordelia Orillac; Nikita Mogar; Donato Pacione; Nidhi Agrawal
Journal:  Pituitary       Date:  2022-05-27       Impact factor: 3.599

7.  A case series of atypical features of patients with biopsy-proven isolated IgG4-related hypophysitis and normal serum IgG4 levels.

Authors:  Kevin C J Yuen; Kelley J Moloney; Jennifer U Mercado; Steven Rostad; Brendan J McCullough; Zachary N Litvack; Johnny B Delashaw; Marc R Mayberg
Journal:  Pituitary       Date:  2018-06       Impact factor: 4.107

Review 8.  Imaging findings in hypophysitis: a review.

Authors:  Ferdinando Caranci; Giuseppe Leone; Andrea Ponsiglione; Massimo Muto; Fabio Tortora; Mario Muto; Sossio Cirillo; Luca Brunese; Alfonso Cerase
Journal:  Radiol Med       Date:  2019-12-20       Impact factor: 3.469

Review 9.  Hypophysitis: An update on the novel forms, diagnosis and management of disorders of pituitary inflammation.

Authors:  Sriram Gubbi; Fady Hannah-Shmouni; Joseph G Verbalis; Christian A Koch
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2019-12-12       Impact factor: 4.690

10.  Diagnosis and management of tumor-like hypophysitis: A retrospective case series.

Authors:  Songxue Guo; Chaohui Wang; Jianmin Zhang; Yong Tian; Qun Wu
Journal:  Oncol Lett       Date:  2015-12-22       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.